Search the Video Library

Filter by Date

Video Language

Filter by Cancer Type:

Displaying Results 1 - 8 of 8

The Importance of Testing and Early Diagnosis
October is Breast Cancer Awareness Month - testing and early diagnosis is crucial for Breast Cancer as well as other cancer types.

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist

2020 MELANOMA - MCKEAN - Combination Immunotherapy vs Monotherapy for Metastatic Melanoma

GRACE is excited to bring you a new series on current updates in Melanoma Treatment Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma service at Memorial Sloan Kettering and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University

Melanoma Updates - AGARWALA - Adjuvant Therapy of Melanoma

GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chiefof Melanoma service at Memorial Sloan Kettering and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University

2020 MELANOMA - MCKEAN - Current Status of Sentinel Lymph Node Mapping & Completion Lymphadenectomy
2020 MELANOMA Updates - Current Status of Sentinel Lymph Node Mapping & Completion Lymphadenectomy

GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma service at Memorial Sloan Kettering and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University

2020 MELANOMA - MCKEAN - Is there a Role for Molecular Testing in Early Melanoma Management
2020 MELANOMA - Is there a Role for Molecular Testing in Early Melanoma Management

GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University

2020 MELANOMA - POSTOW - Future Prospects for Immunotherapy Agents in Advanced Melanoma
2020 MELANOMA - Future Prospects for Immunotherapy Agents in Advanced Melanoma

GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University

2020 MELANOMA - POSTOW - Understanding Immunotherapy Resistance Mechanisms in Melanoma
2020 MELANOMA - Understanding Immunotherapy Resistance Mechanisms in Melanoma

GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University

2020 MELANOMA - POSTOW - What is the Correct Choice for First Line Therapy for BRAF + Melanoma
2020 MELANOMA - What is the Correct Choice for First Line Therapy for BRAF Positive Metastatic Melanoma

GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University